1. Home
  2. ILMN vs BR Comparison

ILMN vs BR Comparison

Compare ILMN & BR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • BR
  • Stock Information
  • Founded
  • ILMN 1998
  • BR 1962
  • Country
  • ILMN United States
  • BR United States
  • Employees
  • ILMN N/A
  • BR N/A
  • Industry
  • ILMN Medical Specialities
  • BR Business Services
  • Sector
  • ILMN Health Care
  • BR Consumer Discretionary
  • Exchange
  • ILMN Nasdaq
  • BR Nasdaq
  • Market Cap
  • ILMN 13.1B
  • BR 28.2B
  • IPO Year
  • ILMN 2000
  • BR 2007
  • Fundamental
  • Price
  • ILMN $100.63
  • BR $242.13
  • Analyst Decision
  • ILMN Buy
  • BR Buy
  • Analyst Count
  • ILMN 16
  • BR 7
  • Target Price
  • ILMN $126.88
  • BR $250.83
  • AVG Volume (30 Days)
  • ILMN 2.3M
  • BR 446.6K
  • Earning Date
  • ILMN 08-05-2025
  • BR 08-05-2025
  • Dividend Yield
  • ILMN N/A
  • BR 1.45%
  • EPS Growth
  • ILMN N/A
  • BR 13.70
  • EPS
  • ILMN N/A
  • BR 6.66
  • Revenue
  • ILMN $4,337,000,000.00
  • BR $6,768,000,000.00
  • Revenue This Year
  • ILMN N/A
  • BR $8.99
  • Revenue Next Year
  • ILMN $3.11
  • BR $4.81
  • P/E Ratio
  • ILMN N/A
  • BR $36.36
  • Revenue Growth
  • ILMN N/A
  • BR 5.72
  • 52 Week Low
  • ILMN $68.70
  • BR $198.18
  • 52 Week High
  • ILMN $156.66
  • BR $247.01
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 81.33
  • BR 46.22
  • Support Level
  • ILMN $88.68
  • BR $232.88
  • Resistance Level
  • ILMN $95.99
  • BR $245.38
  • Average True Range (ATR)
  • ILMN 2.91
  • BR 4.41
  • MACD
  • ILMN 0.93
  • BR -0.18
  • Stochastic Oscillator
  • ILMN 97.37
  • BR 37.27

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About BR Broadridge Financial Solutions Inc.

Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two segments: investor communication solutions and global technology and operations.

Share on Social Networks: